The association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes: a retrospective observational study

BACKGROUND: To evaluate the association of treatment with glucagon-like peptide-1 (GLP-1) receptor agonist exenatide and/or insulin on macrovascular outcomes in patients with type 2 diabetes (T2DM). METHODS: We conducted a retrospective longitudinal pharmaco-epidemiological study using large ambulat...

Descripción completa

Detalles Bibliográficos
Autores principales: Paul, Sanjoy K, Klein, Kerenaftali, Maggs, David, Best, Jennie H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314769/
https://www.ncbi.nlm.nih.gov/pubmed/25616979
http://dx.doi.org/10.1186/s12933-015-0178-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314769/
https://www.ncbi.nlm.nih.gov/pubmed/25616979
http://dx.doi.org/10.1186/s12933-015-0178-3

Ejemplares similares